NGL Fine Chem Ltd.
BSE: 524774 | Sector: Health care |
NSE: N.A. | ISIN Code: INE887E01022 |
BSE 00:00 | 26 May | 1805.40 |
-29.90 (-1.63%) |
OPEN
1847.90 |
HIGH
1848.90 |
LOW
1800.00 |
NSE 05:30 | 01 Jan | NGL Fine Chem Ltd Not listed in NSE |
OPEN | 1847.90 |
PREVIOUS CLOSE | 1835.30 |
VOLUME | 3137 |
52-Week high | 3789.45 |
52-Week low | 1680.05 |
P/E | 21.36 |
Mkt Cap.(Rs cr) | 1,116 |
Buy Price | 0.00 |
Buy Qty | 0.00 |
Sell Price | 0.00 |
Sell Qty | 0.00 |
About NGL Fine Chem Ltd.
The Company was incorporated on December 18 1981 as a Private Limited Company in the State of Maharashtra. The Company became a Deemed Limited Company by virtue of Section 43A of the Companies Act 1956 on 29.12.1993 and the necessary alternation to the Certificate of Incorporation was duly obtained from the Registrar of Companies Maharashtra. The Company has deleted the restrictive clauses in the ...> More
NGL Fine Chem Ltd - Key Fundamentals
Parameter | Values | ||
Market Cap | (![]() |
1,116 | |
EPS - TTM | (![]() |
[*S] | 84.54 |
P/E Ratio | (X) | [*S] | 21.36 |
Face Value | (![]() |
5 | |
Latest Dividend | (%) | 35.00 | |
Latest Dividend Date | 22 Jun 2022 | ||
Dividend Yield | (%) | 0.10 | |
Book Value / Share | (![]() |
[*S] | 334.26 |
P/B Ratio | (![]() |
[*S] | 5.40 |
Announcement
-
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
-
Announcement under Regulation 30 (LODR)-Investor Presentation
NGL Fine Chem Ltd - Financial Results
Particulars (![]() |
Mar 2022 | Mar 2021 | % Chg |
Net Sales | 84.06 | 71.77 | 17.12 |
Other Income | 2.98 | 2.3 | 29.57 |
Total Income | 87.04 | 74.07 | 17.51 |
Total Expenses | 73.5 | 50.98 | 44.17 |
Operating Profit | 13.54 | 23.09 | -41.36 |
Net Profit | 6.87 | 13.84 | -50.36 |
Equity Capital | 3.09 | 3.09 | - |
NGL Fine Chem Ltd - Peer Group
Company | Price(![]() |
Chg (%) | Mkt Cap (![]() |
Neuland Labs. | 976.30 | -2.52 | 1252.59 |
Orchid Pharma | 284.35 | -0.11 | 1160.72 |
Suven Life Scie. | 77.60 | 2.17 | 1128.30 |
NGL Fine Chem | 1805.40 | -1.63 | 1115.74 |
Kopran | 222.90 | 2.51 | 1074.60 |
TTK Healthcare | 745.35 | 1.84 | 1053.18 |
Panacea Biotec | 141.20 | -0.07 | 865.56 |
NGL Fine Chem Ltd - SHAREHOLDING PATTERN
|
|
NGL Fine Chem Ltd - RETURNS
Period | BSE | NSE | Sensex | NIFTY |
1 Week | -7.45% | NA | 2.77% | 2.28% |
1 Month | -17.42% | NA | -5.41% | -5.99% |
3 Month | -16.91% | NA | -2.88% | -2.93% |
6 Month | -32.74% | NA | -5.00% | -5.03% |
1 Year | -1.98% | NA | 6.34% | 5.68% |
3 Year | 302.09% | NA | 37.58% | 36.52% |
NGL Fine Chem Ltd - STOCK STRENGTH
Today's Low/High | 1800.00 | 1848.90 | |
Week Low/High | 1800.00 | 1999.00 | |
Month Low/High | 1755.60 | 2398.00 | |
YEAR Low/High | 1680.05 | 3789.00 | |
All TIME Low/High | 0.40 | 3789.00 |
Quick Links for NGL Fine Chem:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices